Read into the latest PV AI Best Practices, discover how to apply the EU AI Act 2023.
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
Read into the implications of the latest guidance from the FDA on registries usefulness for various purposes and how to best build one.
Utilizing AI-powered analytics for your patient services data can help unlock benefits that ultimately improve patient outcomes.
The use of real-world evidence has greatly expanded in recent years but is still underutilized by emerging biotechs.
Learn more about how to utilize Knowledge, Attitude, and Behavior Surveys to evaluate stakeholders in your REMS program.
With recent changes for pharmacists and pharmacies, it is beneficial for patient access to invest in relationships with these partners.
There are numerous insights to unlock within your patient services program data – but do you know where and how to look?
Learn the optimal approach for considering technology enhancements to your existing patient services program.
As the US biosimilar market expands rapidly, discover why real-world evidence can unlock your market access.